1. UOBScholar Hub
  2. Faculties and Departments
  3. Faculty of Medicine
Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6834
DC FieldValueLanguage
dc.contributor.authorBindal, Poorvaen_US
dc.contributor.authorNajjar, Mimien_US
dc.contributor.authorKoehn, Kellyen_US
dc.contributor.authorGodara, Amandeepen_US
dc.contributor.authorSborov, Douglas Wen_US
dc.contributor.authorMcClune, Brianen_US
dc.contributor.authorJulian, Kelleyen_US
dc.contributor.authorWagner, Charlotteen_US
dc.contributor.authorMohyuddin, Ghulam Rehmanen_US
dc.date.accessioned2023-05-29T09:47:33Z-
dc.date.available2023-05-29T09:47:33Z-
dc.date.issued2023-05-11-
dc.identifier.issn10428194-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/6834-
dc.language.isoengen_US
dc.publisherNational Library of Medicineen_US
dc.titleRefractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trialsen_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1080/10428194.2023.2209682-
dc.identifier.pmid37170589-
dc.identifier.scopus2-s2.0-85159104222-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85159104222-
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume64en_US
dc.description.issue7en_US
dc.description.startpage1340en_US
dc.description.endpage1343en_US
dc.date.catalogued2023-05-29-
dc.description.statusPublisheden_US
dc.identifier.ezproxyURLhttp://ezsecureaccess.balamand.edu.lb/login?url=https://doi.org/10.1080/10428194.2023.2209682en_US
dc.relation.ispartoftextLeukemia and Lymphomaen_US
Appears in Collections:Faculty of Medicine
Show simple item record

Record view(s)

44
checked on Sep 6, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.